Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sepsis Prognosis and Diagnosis in the Emergency Department Using a Host Response Classifier (SPEED) UK - a Multi-Centre Observational Study

NCT05639504 is registered in ClinicalTrials.gov with Inflammatix as lead sponsor.

NCT NCT05639504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05639504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sepsis Prognosis and Diagnosis in the Emergency Department Using a Host Response Classifier (SPEED) UK - a Multi-Centre Observational Study
Lead sponsor
Inflammatix
Phase
Observational
Overall status
Withdrawn
Start date
December 31, 2022
Completion date
May 31, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intra-abdominal infections, respiratory tract infections, sepsis, skin and soft tissue infection, suspected meningitis/encephalitis or any other infection, urinary tract infections